News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2020 Shelley Wood November 30, 2020
News Conference News AHA 2020 OMEMI: Omega-3 Fatty Acids No Help in Elderly MI Patients Todd Neale November 15, 2020
News Conference News AHA 2020 Fish Oil Tanks in STRENGTH, Making Waves for REDUCE-IT Todd Neale November 15, 2020
News Daily News More Circulating Omega-3s May Boost Prognosis After STEMI Todd Neale October 26, 2020
News Conference News TCT 2020 Icosapent Ethyl’s Benefits Consistent in Patients With Prior PCI: REDUCE-IT Todd Neale October 21, 2020
News Daily News New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts Michael O'Riordan August 06, 2020
Presentation SCAI 2020 Reduction of Revascularization in Patients with Hypertriglyceridemia with Icosapent Ethyl: Insights from REDUCE-IT REVASC Presenter: Benjamin E. Peterson May 21, 2020
News Conference News SCAI 2020 Icosapent Ethyl Lowers Revasc Rates Across the Board: REDUCE-IT Data Caitlin E. Cox May 15, 2020
News Conference News ACC 2020 Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT Todd Neale April 02, 2020
News Opinion Editor's Corner A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out Shelley Wood March 16, 2020
News Daily News Habitual Use of Fish Oil Prevents CVD, Real-world Data Suggest Todd Neale March 05, 2020
News Daily News Most Secondary Prevention Patients Are Eligible for Multiple Drugs Michael O'Riordan January 03, 2020